Theories of Antibodies Production
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Ch. 43 the Immune System
Ch. 43 The Immune System 1 Essential Questions: How does our immunity arise? How does our immune system work? 2 Overview of immunity: Two kinds of defense: A. innate immunity present at time of birth before exposed to pathogens nonspecific responses, broad in range skin and mucous membranes internal cellular and chemical defenses that get through skin macrophages, phagocytic cells B. acquired immunity (adaptive immunity)develops after exposure to specific microbes, abnormal body cells, foreign substances or toxins highly specific lymphocytes produce antibodies or directly destroy cells 3 Overview of Immune System nonspecific Specific 4 I. Innate immunity Nonspecific defenses A. First line of defense: skin, mucous membranes skin protects against chemical, mechanical, pathogenic, UV light damage mucous membranes line digestive, respiratory, and genitourinary tracts prevent pathogens by trapping in mucus *breaks in skin or mucous membranes = entryway for pathogen 5 secretions of skin also protect against microbes sebaceous and sweat glands keep pH at 35 stomach also secretes HCl (Hepatitis A virus can get past this) produce antimicrobial proteins (lysozyme) ex. in tears http://vrc.belfastinstitute.ac.uk/resources/skin/skin.htm 6 B. Second line of defense internal cellular and chemical defenses (still nonspecific) phagocytes produce antimicrobial proteins and initiate inflammation (helps limit spread of microbes) bind to receptor sites on microbe, then engulfs microbe, which fused with lysosome nitric oxide and poisons in lysosome can poison microbe lysozyme and other enzymes degrade the microbe *some bacteria have capsule that prevents attachment *some bacteria are resistant to lysozyme macrophages 7 Cellular Innate defenses Tolllike receptor (TLR) recognize fragments of molecules characteristic of a set of pathogens [Ex. -
MINIREVIEW Idiotypic Vaccines and Infectious Diseases JACQUES R
INFECTION AND IMMUNITY, June 1988, p. 1407-1413 Vol. 56, No. 6 0019-9567/88/061407-07$02.00/0 Copyright © 1988, American Society for Microbiology MINIREVIEW Idiotypic Vaccines and Infectious Diseases JACQUES R. HIERNAUX Laboratory of Microbial Immunity, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892 INTRODUCTION If we accept the view that idiotypic interactions play a role in the regulation of the immune response to infectious The discovery of vaccination by Jenner, as well as the agents, various types of idiotypic manipulations (the injec- development of the principle of vaccines by Pasteur, had an tion of internal-image-bearing antibody being one of them) enormous impact on the eradication of many infectious could influence ongoing regulatory processes. On the basis diseases. These developments opened the road to the devel- of the idiotypic-network hypothesis, the idiotypic cascade opment of attenuated (i.e., live) or inactivated (i.e., nonin- presented in Fig. 1 can fectious) vaccines; however, such vaccines are not without be developed. Figure 1 follows problems and can have detrimental effects. Indeed, attenu- Jerne's original assumption that paratopes and idiotopes are ated vaccines can revert to a more virulent form, and distinct functional entitites. This allows us to deduce which inactivated vaccines may produce serious side effects. There interactions can potentially occur within the idiotypic cas- also are several infectious diseases for which no vaccines cade. For the sake of simplicity, I only present some of the are available. For example, many parasitic infections cannot members of the cascade and consider one or two idiotopes be prevented by vaccination. -
The RAG Recombinase Dictates Functional Heterogeneity and Cellular Fitness in Natural Killer Cells
The RAG Recombinase Dictates Functional Heterogeneity and Cellular Fitness in Natural Killer Cells Jenny M. Karo,1 David G. Schatz,2 and Joseph C. Sun1,* 1Immunology Program and Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA 2Department of Immunobiology and the Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.cell.2014.08.026 SUMMARY completely absent (Mombaerts et al., 1992; Shinkai et al., 1992). There is as yet no evidence that RAG plays a physiological The emergence of recombination-activating genes role in any cell type other than B and T lymphocytes or in any pro- (RAGs) in jawed vertebrates endowed adaptive cess other than V(D)J recombination. immune cells with the ability to assemble a diverse Although NK cells have long been classified as a component set of antigen receptor genes. In contrast, innate of the innate immune system, recent evidence suggests that lymphocytes, such as natural killer (NK) cells, are this cell type possesses traits attributable to adaptive immunity not believed to require RAGs. Here, we report that (Sun and Lanier, 2011). These characteristics include ‘‘educa- tion’’ mechanisms to ensure self-tolerance during NK cell devel- NK cells unable to express RAGs or RAG endonu- opment and clonal-like expansion of antigen-specific NK clease activity during ontogeny exhibit a cell-intrinsic cells during viral infection, followed by the ability to generate hyperresponsiveness but a diminished capacity long-lived ‘‘memory’’ NK cells. -
Anti-Idiotype Antibody Generation and Application in Antibody Drug Discovery
Anti-idiotype Antibody Generation and Application in Antibody Drug Discovery Liusong Yin, PhD Senior Scientist, Group Leader Antibody Discovery, Antibody Department, GenScript [email protected] Apr 21st, 2016 Presentation Overview Anti-idiotype antibody introduction 1 2 Anti-idiotype antibody application 3 Anti-idiotype antibody development 4 Anti-idiotype antibody case study Make Research Easy 2 Structural overview of antibodies PDB ID: 1HZH Liusong Yin, 2014, A Dissertation Make Research Easy 3 Antibody ‘-types’ Isotype (species specific)– the phenotypic variations in the constant regions of the heavy and light chains Allotype (animal specific)– the genetically determined difference in antibodies between individuals in the same species, mainly a couple AA differences in constant region Idiotype (antigen specific)– the antigen binding specificity defined by the distinctive sequence in the variable region of antibodies Make Research Easy 4 ‘-topes’ in anti-idiotype antibodies (anti-IDs) Idiotope – the antigenic determinants in or close to the complementarity determining region (CDR) in variable region Epitope Paratope Paratope – the part of an Ab that recognizes an antigen, the antigen-binding site of an Ab Epitope – the part of the antigen to which the paratope binds Anti-IDs – anti-idiotype antibodies which recognize the shared feature of idiotopes Make Research Easy 5 Different types of Anti-IDs Antigen-blocking Non-blocking Complex-specific Anti-ID Drug Target Anti-ID Anti-ID Antibody drug Antibody drug Antibody drug -
LECTURE 05 Acquired Immunity and Clonal Selection
LECTURE: 05 Title: ACQUIRED "ADAPTIVE" IMMUNITY & CLONAL SELECTION THEROY LEARNING OBJECTIVES: The student should be able to: • Recognize that, acquired or adaptive immunity is a specific immunity. • Explain the mechanism of development of the specific immunity. • Enumerate the components of the specific immunity such as A. Primary immune response. B. Secondary immune response • Explain the different phases that are included in the primary and secondary immune responses such as: A. The induction phase. B. Exponential phase. C. Steady phase. D. Decline phase. • Compare between the phases of the primary and secondary immune responses. • Determine the type of the immunoglobulins involved in each phase. • Determine which immunoglobulin is induced first and, that last longer. • Enumerate the characteristics of the specific immunity such as: A. The ability to distinguish self from non-self. B. Specificity. C. Immunological memory. • Explain naturally and artificially acquired immunity (passive, and active). • Explain the two interrelated and independent mechanisms of the specific immune response such as : A. Humoral immunity. B. Cell-mediated (cellular) immunity. • Recognize that, the specific immunity is not always protective, for example; sometimes it causes allergies (hay fever), or it may be directed against one of the body’s own constituents, resulting in autoimmunity (thyroditis). LECTURE REFRENCE: 1. TEXTBOOK: ROITT, BROSTOFF, MALE IMMUNOLOGY. 6th edition. Chapter 2. pp. 15-31 2. TEXTBOOK: ABUL K. ABBAS. ANDREW H. LICHTMAN. CELLULAR AND MOLECULAR IMMUNOLOGY. 5TH EDITION. Chapter 1. pg 3-12. 1 ACQUIRED (SPECIFIC) IMMUNITY INTRODUCTION Adaptive immunity is created after an interaction of lymphocytes with particular foreign substances which are recognized specifically by those lymphocytes. -
Med-Pathway Zoom Workshop
MCAT Immunology Dr. Phillip Carpenter medpathwaymcat Med-pathway AAMC MCAT Content Outline: Immunology Category 1A: Structure/Function of Proteins/AA Immune System Category 3B: Organ Systems Innate vs. Adaptive Immunity T and B Lymphocytes Macrophages & Phagocytes Tissue-Bone marrow, Spleen, Thymus, Lymph nodes Antigen and Antibody Antigen Presentation Clonal Selection Antigen-Antibody recognition Structure of antibody molecule Self vs. Non-self, Autoimmune Diseases Major Histocompatibility Complex Lab Techniques: ELISA & Western Blotting Hematopoiesis Creates Immune Cells Self vs. Non-self Innate vs Adaptive Innate Immunity Physical Barriers: Skin, mucous membranes, pH Inflammatory mediators: Complement, Cytokines, Prostaglandins Cellular Components: Phagocytes-Neutrophils, Eosinophils, Basophils, Mast Cells Antigen Presenting Cells-Monocytes, Macrophages, Dendritic Cells Adaptive (Acquired) Immunity Composed of B and T lymphocytes: Activated by Innate Immunity B cells: Express B cell receptor and secrete antibodies as plasma cells T cells: Mature in thymus, express TCR surface receptor; Activated by Antigen Presenting Cells (APCs) Direct Immune response (The Ringleaders of immune system) Major Lymphoid Organs TYPE SITE FUNCTION Fetal production of Liver 1° lymphoid cells Hematopoietic production of 1° Bone marrow myeloid and lymphoid cells Receives bone marrow T 1° Thymus cells; site where self is selected from non-self Lymph nodes 2° Sites of antigen activation Spleen of lymphocytes; clearance Macrophages (Sentinel Cells) Pattern Recognition -
A Series of Adaptive Models Inspired by the Acquired Immune System
A Series of Adaptive Models Inspired by the Acquired Immune System JASON BROWNLEE Technical Report 070227A Complex Intelligent Systems Laboratory, Centre for Information Technology Research, Faculty of Information Communication Technology, Swinburne University of Technology Melbourne, Australia [email protected] Abstract-The acquired immune system is capable of the presented series of adaptive models as a novel specialising a defence of an organism in response to the its hierarchal framework for which existing and future antigenic environment. This complex biological system possess acquired immunity inspired adaptive models may be interesting information processing features such as learning, interpreted and related. memory, and the ability to generalize. The clonal selection theory is a cornerstone of modern biology in understanding the acquired II. PRINCIPLE COMPONENTS immune system from the perspective of B-lymphocyte cells and This section lists a series of principles (operators or antibody diversity. This work presents a series of computational mechanisms) that are sufficiently low in complexity to adaptive systems inspired by features of the biological immune be analysed independently. It is expected that the system and the clonal selection theory in particular. Starting with mechanisms listed in this section may act as component basic clonal operators as principle components, models are features in larger adaptive models. Operators are presented in increasing complexity from canonical clonal assigned a notation of O# and -
A Network Model for Clonal Differentiation and Immune Memory
ARTICLE IN PRESS Physica A 355 (2005) 408–426 www.elsevier.com/locate/physa A network model for clonal differentiation and immune memory Alexandre de Castroa,b,Ã aCentro Regional VI, Universidade Estadual do Rio Grande do Sul 90010-030, Porto Alegre, RS, Brazil bInstituto de Fı´sica, Universidade Federal do Rio Grande do Sul 91501-970, Porto Alegre, RS, Brazil Received 21 June 2004 Available online 17 May 2005 Abstract A model of bit-strings, that uses the technique of multi-spin coding, was previously used to study the time evolution of B-cell clone repertoire, in a paper by Lagreca, Almeida and Santos. In this work we extend that simplified model to include independently the role of the populations of antibodies, in the control of the immune response, producing mechanisms of differentiation and regulation in a more complete way. Although the antibodies have the same molecular shape of the B-cells receptors (BCR), they should present a different time evolution and thus should be treated separately. We have also studied a possible model for the network immune memory, suggesting a random memory regeneration, which is self-perpetuating. r 2005 Elsevier B.V. All rights reserved. Keywords: Immune memory; Antibodies evolution; Memory regenerating 1. Introduction In the last decades, due in part to the spread of the world AIDS epidemy, the scientific community started to dedicate special attention to the immunological system, responsible for the defense of the organism against microscopic invaders. ÃCorresponding author. Centro Regional VI, Universidade Estadual do Rio Grande do Sul 90010-030, Porto Alegre, RS, Brazil. -
Jerne's Anti-Idiotypic Network Theory Cannot Explain Self-Nonself
Journal of Alternative Medicine Research ISSN: 1939-5868 Volume 1, Issue 4, pp.439-444 © 2009 Nova Science Publishers, Inc. Human development XVII: Jerne’s anti-idiotypic network theory cannot explain self-nonself discrimination Søren Ventegodt∗1,2,3,4,5, Tyge Dahl Abstract Hermansen1, Isack Kandel6,7 and Joav Merrick5,7,8,,9 In this paper we propose that self-nonself discrimination 1 takes place at a supra-cellular systemic level and involves Quality of Life Research Center, Classensgade 11C, 1 selective activation of immune cell precursors. We discuss sal, DK-2100 Copenhagen O, Denmark; this activation, the further differentiation to active 2Research Clinic for Holistic Medicine and lymphocytes, and the following immune response induced 3Nordic School of Holistic Medicine, Copenhagen, by the system permitting all relevant information to be Denmark; involved in the “decision” process in a dynamic way. We 4Scandinavian Foundation for Holistic Medicine, discuss Jerne’s immunological network theory based on the capability of self-nonself discrimination and we discuss if Sandvika, Norway; 5 his immunological network theory is able to carry out such Interuniversity College, Graz, Austria; self-nonself discrimination. We argue that this is not the 6 Faculty of Social Sciences, Department of Behavioral case. We discuss the immune tolerance that seems not to be Sciences, Ariel University Center of Samaria, Ariel, transferred with the immune cells, what Jerne’s network Israel; model involves as a necessity. We discuss Jerne’s 7National Institute of Child Health and Human idiotypical network’s capability of being expanded to include T-cells. Also here we argue that this is not the case. -
Anti-Idiotypic Antibodies and “Tumor-Only” Antigens: an Update Alejandro López-Requenaa,B and Oscar R
The Open Immunology Journal, 2009, 2, 1-8 1 Open Access Anti-Idiotypic Antibodies and “Tumor-Only” Antigens: An Update Alejandro López-Requenaa,b and Oscar R. Burrone*,b aDepartment of Antibody Engineering, Center of Molecular Immunology, P.O. Box 16040, Havana 11600, Cuba bMolecular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34012 Trieste, Italy Abstract: The use of anti-idiotypic antibodies for cancer treatment continues to be a major field of investigation. One ma- jor challenge for tumor immunotherapy is the identification of antigens associated only or preferably with malignant cells. We summarize here some of the most recent preclinical and clinical advances using two targets that can be considered tumor-specific antigens: N-glycolyl (NeuGc)-gangliosides and the idiotype of B cell lymphomas. Recent developments with tumor-associated protein antigens and the role of anti-idiotypic antibodies in autoimmune diseases are also discussed. Keywords: Anti-idiotypic antibodies, NeuGc, ganglioside, idiotype, B cell lymphoma. INTRODUCTION antigen. The generation of anti-idiotypic antibodies against Ab2 (anti-Ab2 or Ab3) with the same specificity of the Ab1 From the pioneer works by Oudin and Kunkel [1, 2], (Ab1’) can be impaired by the peripheral tolerance mecha- where the existence of individual antigenic determinants of nisms of the organism even when the Ab2 carries the “inter- the immunoglobulins (idiotopes) was demonstrated, to nal image” of the antigen [6]. Jerne’s Idiotypic Network Theory [3]; through Bona’s “regu- latory idiotope” [4] and Coutinho’s “second generation” Anti-idiotypic antibodies have been widely used for can- networks [5], the theory around anti-idiotypic antibodies has cer immunotherapy [7]. -
Anti-Idiotypic Antibodies Against a Human Multiple Organ- Reactive Autoantibody
Anti-idiotypic antibodies against a human multiple organ- reactive autoantibody. Detection of idiotopes in normal individuals and patients with autoimmune diseases. K Essani, … , P R McClintock, A L Notkins J Clin Invest. 1985;76(4):1649-1656. https://doi.org/10.1172/JCI112150. Research Article We have recently isolated and characterized a human monoclonal autoantibody, MOR-h1 (multiple organ-reactive human 1), that reacts with antigens in multiple organs and have shown that this antibody binds to human growth hormone and a 35,000-mol wt protein. In the present study we generated three monoclonal anti-idiotypic antibodies (4E6, 3E5, and 3F6) against MOR-h1. These anti-idiotypic antibodies specifically reacted with MOR-h1 and not with 26 other multiple organ- reactive monoclonal IgM autoantibodies nor with pooled human IgM (myeloma proteins). The binding of the anti-idiotypic antibodies to MOR-h1 was inhibited by both human growth hormone and the 35,000-mol wt protein, which strongly suggests that these antibodies react with epitopes at or near the paratope on MOR-h1. The results of competitive binding experiments revealed that the epitope recognized by 4E6 is distinct from that recognized by 3E5 and 3F6. Using these anti-idiotypic antibodies, lymphocytes and sera from normal individuals were tested for the presence of the 4E6 and 3E5/3F6 idiotopes. By indirect immunofluorescence, the 4E6 idiotope was detected on an average of 1.1% of normal circulating B lymphocytes, and by enzyme-linked immunosorbent assays, the 4E6 and to a lesser extent the 3E5/3F6 idiotopes were found on IgG molecules in sera of normal individuals. -
Interplay of Natural Killer Cells and Their Receptors with the Adaptive Immune Response
REVIEW BRIDGING INNATE AND ADAPTIVE IMMUNITY Interplay of natural killer cells and their receptors with the adaptive immune response David H Raulet Although natural killer (NK) cells are defined as a component of the innate immune system, they exhibit certain features generally considered characteristic of the adaptive immune system. NK cells also participate directly in adaptive immune responses, mainly by interacting with dendritic cells. Such interactions can positively or negatively regulate dendritic cell activity. Reciprocally, dendritic cells regulate NK cell function. In addition, ‘NK receptors’ are frequently expressed by T cells and can directly regulate the functions of these cells. In these distinct ways, NK cells and their receptors influence the adaptive http://www.nature.com/natureimmunology immune response. Natural killer (NK) cells, a component of the innate immune system, Themes of NK cell recognition mediate cellular cytotoxicity and produce chemokines and inflamma- The recognition strategies used by NK cells are diverse. These include tory cytokines such as interferon-γ (IFN-γ) and tumor necrosis factor recognition of pathogen-encoded molecules; recognition of self pro- (TNF), among other activities1. They are important in attacking teins whose expression is upregulated in transformed or infected cells pathogen-infected cells, especially during the early phases of an infec- (‘induced-self recognition’); and inhibitory recognition of self pro- tion1,2. They are also efficient killers of tumor cells and are believed to be teins that are expressed by normal cells but downregulated by infected involved in tumor surveillance. The long-standing hypothesis that NK or transformed cells (‘missing-self recognition’). What follows are cells exert an immunoregulatory effect is supported by recent evidence examples of each.